Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells.

Santamaria-Barria JA, Zeng S, Greer JB, Beckman MJ, Seifert AM, Cohen NA, Zhang JQ, Crawley MH, Green BL, Loo JK, Maltbaek JH, DeMatteo RP.

PLoS One. 2019 May 1;14(5):e0216275. doi: 10.1371/journal.pone.0216275. eCollection 2019.

2.

Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity.

Medina BD, Liu M, Vitiello GA, Seifert AM, Zeng S, Bowler T, Zhang JQ, Cavnar MJ, Loo JK, Param NJ, Maltbaek JH, Rossi F, Balachandran V, DeMatteo RP.

J Exp Med. 2019 Jun 3;216(6):1359-1376. doi: 10.1084/jem.20180660. Epub 2019 Apr 18.

PMID:
31000683
3.

Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors.

Zhang JQ, Zeng S, Vitiello GA, Seifert AM, Medina BD, Beckman MJ, Loo JK, Santamaria-Barria J, Maltbaek JH, Param NJ, Moral JA, Zhao JN, Balachandran V, Rossi F, Antonescu CR, DeMatteo RP.

Cancer Immunol Res. 2018 Apr;6(4):434-447. doi: 10.1158/2326-6066.CIR-17-0345. Epub 2018 Feb 21.

4.

ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor.

Zeng S, Seifert AM, Zhang JQ, Kim TS, Bowler TG, Cavnar MJ, Medina BD, Vitiello GA, Rossi F, Loo JK, Param NJ, DeMatteo RP.

Oncotarget. 2017 Dec 11;8(69):114195-114209. doi: 10.18632/oncotarget.23173. eCollection 2017 Dec 26.

5.

Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor.

Zeng S, Seifert AM, Zhang JQ, Cavnar MJ, Kim TS, Balachandran VP, Santamaria-Barria JA, Cohen NA, Beckman MJ, Medina BD, Rossi F, Crawley MH, Loo JK, Maltbaek JH, Besmer P, Antonescu CR, DeMatteo RP.

Mol Cancer Ther. 2017 Sep;16(9):1954-1966. doi: 10.1158/1535-7163.MCT-17-0139. Epub 2017 Jun 13.

6.

Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.

Sorenson EC, Khanin R, Bamboat ZM, Cavnar MJ, Kim TS, Sadot E, Zeng S, Greer JB, Seifert AM, Cohen NA, Crawley MH, Green BL, Klimstra DS, DeMatteo RP.

PLoS One. 2017 May 9;12(5):e0176562. doi: 10.1371/journal.pone.0176562. eCollection 2017.

7.

Apps in therapy: occupational therapists' use and opinions.

Seifert AM, Stotz N, Metz AE.

Disabil Rehabil Assist Technol. 2017 Nov;12(8):772-779. doi: 10.1080/17483107.2016.1262912. Epub 2016 Dec 16.

PMID:
27982716
8.

PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.

Seifert AM, Zeng S, Zhang JQ, Kim TS, Cohen NA, Beckman MJ, Medina BD, Maltbaek JH, Loo JK, Crawley MH, Rossi F, Besmer P, Antonescu CR, DeMatteo RP.

Clin Cancer Res. 2017 Jan 15;23(2):454-465. doi: 10.1158/1078-0432.CCR-16-1163. Epub 2016 Jul 28.

9.

Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors.

Cohen NA, Zeng S, Seifert AM, Kim TS, Sorenson EC, Greer JB, Beckman MJ, Santamaria-Barria JA, Crawley MH, Green BL, Rossi F, Besmer P, Antonescu CR, DeMatteo RP.

Cancer Res. 2015 May 15;75(10):2061-70. doi: 10.1158/0008-5472.CAN-14-2564. Epub 2015 Apr 2.

10.

Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor.

Kim TS, Cavnar MJ, Cohen NA, Sorenson EC, Greer JB, Seifert AM, Crawley MH, Green BL, Popow R, Pillarsetty N, Veach DR, Ku AT, Rossi F, Besmer P, Antonescu CR, Zeng S, Dematteo RP.

Clin Cancer Res. 2014 May 1;20(9):2350-62. doi: 10.1158/1078-0432.CCR-13-3033. Epub 2014 Feb 28.

11.

KIT oncogene inhibition drives intratumoral macrophage M2 polarization.

Cavnar MJ, Zeng S, Kim TS, Sorenson EC, Ocuin LM, Balachandran VP, Seifert AM, Greer JB, Popow R, Crawley MH, Cohen NA, Green BL, Rossi F, Besmer P, Antonescu CR, DeMatteo RP.

J Exp Med. 2013 Dec 16;210(13):2873-86. doi: 10.1084/jem.20130875. Epub 2013 Dec 9.

12.

[Include representations of caregivers coping with nosocomial Clostridium difficile in Quebec to promote better health].

Seifert AM, O'Neill M.

Glob Health Promot. 2013 Sep;20(3):58-65. doi: 10.1177/1757975913496123. French. No abstract available.

PMID:
23986384
13.

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

Gasch C, Bauernhofer T, Pichler M, Langer-Freitag S, Reeh M, Seifert AM, Mauermann O, Izbicki JR, Pantel K, Riethdorf S.

Clin Chem. 2013 Jan;59(1):252-60. doi: 10.1373/clinchem.2012.188557. Epub 2012 Nov 7.

14.

Precarious employment conditions affect work content in education and social work: results of work analyses.

Seifert AM, Messing K, Riel J, Chatigny C.

Int J Law Psychiatry. 2007 Jul-Oct;30(4-5):299-310. Epub 2007 Jul 13.

PMID:
17631963
16.

Understanding women's work: steps toward transformation--an introduction.

Seifert AM, Messing K.

New Solut. 2007;17(1-2):53-6.

PMID:
17434858
17.

Qualitative research using numbers: an approach developed in france and used to transform work in north america.

Messing K, Seifert AM, Vézina N, Balka E, Chatigny C.

New Solut. 2005;15(3):245-60.

PMID:
17208833
18.

The 120-S minute: using analysis of work activity to prevent psychological distress among elementary school teachers.

Messing K, Seifert AM, Escalona E.

J Occup Health Psychol. 1997 Jan;2(1):45-62.

PMID:
9552279
19.
20.

Evaluation of exposure data from men and women with the same job title.

Messing K, Dumais L, Courville J, Seifert AM, Boucher M.

J Occup Med. 1994 Aug;36(8):913-7.

PMID:
7807275
22.

Nuclear medicine patients do not have higher mutant frequencies after exposure to thallium-201.

Bachand M, Seifert AM, Messing K.

Mutat Res. 1991 Jan;262(1):1-6.

PMID:
1986278
23.

Use of antibiotic-loaded bone cement in the management of common infections of the foot and ankle.

Jacobs AM, Seifert AM, Kirisits TJ, Protzel HR.

Clin Podiatr Med Surg. 1990 Jul;7(3):523-44. Review.

PMID:
2205350
24.

Mutant frequency of radiotherapy technicians appears to be associated with recent dose of ionizing radiation.

Messing K, Ferraris J, Bradley WE, Swartz J, Seifert AM.

Health Phys. 1989 Oct;57(4):537-44.

PMID:
2793468
25.

Exposure of nuclear medicine patients to ionizing radiation is associated with rises in HPRT- mutant frequency in peripheral T-lymphocytes.

Seifert AM, Bradley WE, Messing K.

Mutat Res. 1987 May;191(1):57-63. No abstract available.

PMID:
3494940
26.

A HindIII RFLP for the HPRT pseudogene on chromosome 3 (HPRTP1).

Dobrovic A, Gareau P, Seifert AM, Messing K, Bradley WE.

Nucleic Acids Res. 1987 Feb 11;15(3):1346. No abstract available.

27.
28.

In vivo mutant frequency of technicians professionally exposed to ionizing radiation.

Messing K, Seifert AM, Bradley WE.

Prog Clin Biol Res. 1986;207:87-97. No abstract available.

PMID:
3008193
29.

Operant performance of rats reared for short and long periods on nutritionally adequate diets varied in fat, carbohydrate, and protein content.

Seifert AM, Thomas DW, Mayer J.

J Gen Psychol. 1971 Oct;85(2d Half):155-63. No abstract available.

PMID:
5127958
30.

Spontaneous activity of rats on diets varied in protein, carbohydrate and fat content.

Seifert AM, Mayer J.

Experientia. 1967 May 15;23(5):395-6. No abstract available.

PMID:
6065788

Supplemental Content

Loading ...
Support Center